Our first Together Separately livestream of 2026 will recap IASLC's Targeted Therapies of #LungCancer meeting, which takes place this week. Sign up now and join us on Wednesday, March 11 at 4pm ET to hear updates from Dr. Joshua Reuss and our moderator, Dr. Isabel Preeshagul. LCRF.org/together

Today is #InternationalDayofWomenandGirlsinScience - and at LCRF, we are proud to support the many women who lead our research and education programs, move lung cancer research forward in the lab and in practice, and chart the course for innovation in science for the betterment of others.

In our winter science update, Aubrey Rhodes, Dr. Toni Wozniak, and Dr. Dhru Deb talk about this year’s research grant program, including research on environmental factors and #LungCancer, and how previous research is connected to treatments now benefiting patients: LCRF.org/scienceteamupdate

Today is #WorldCancerDay - and a day to celebrate a small, but hard-won victory. Yesterday, the House passed the funding measure to end the ongoing partial government shutdown, which includes funding for the Defense Appropriations Act, which provides $20 million for the Lung Cancer Research Program.

Future You will thank you for this one. Creating or updating your will is one of the most meaningful ways to plan for tomorrow. It’s quick, free, and gives you peace of mind for your future – and the future of research that improves outcomes for patients with #LungCancer. LCRF.org/qt6ay

Today is the last day of Radon Awareness Month, but it is never too late to learn more about one of the leading causes of #lungcancer. Visit LCRF.org/radon today.

#ICYMI - The FDA approved amivantamab to be given subcutaneously (under the skin) for patients whose conditions already were approved for intravenous (IV) use of this bispecific antibody. LCRF's Chief Scientific Officer, Dr. Antoinette Wozniak, explains what this means. #LungCancer LCRF.org/9906f

#ICYMI - The winter LCRF e-news is out! Read about the impact your support has on research and the future of #LungCancer. LCRF.org/enews

2025 was a tremendous year for #LungCancer research. LCRF's Chief Scientific Officer, Antoinette Wozniak, MD, outlines the developments and what they mean going forward. #ScienceMadeSimple LCRF.org/hizrw

Future You will thank you for this one. Creating or updating your will is one of the most meaningful ways to plan for tomorrow. It’s quick, free, and gives you peace of mind for your future and the future of research, to improve outcomes for patients with #LungCancer: LCRF.org/qt6ay

Radon is the 2nd leading cause of #LungCancer. The highest levels of radon are found below ground – basements, crawlspaces, foundations, and construction joints. Some states have higher levels than others. Check your state’s radon levels here: buff.ly/k3OZfbn

Take action now! Ask your representative to co-sponsor the Benay Taub Lung Cancer Research Act, a bipartisan bill that would: 🫁 Improve access to lung cancer screenings 🫁 Recommend best practices for early detection 🫁 Increase federal funding for research lungcan.org/bt

January is Radon Action & Awareness Month! It's time to increase the public's awareness of radon as a leading cause of #LungCancer, promote radon testing and mitigation, and advance the use of radon-resistant construction practices. Learn how to protect your home and family: LCRF.org/radon

Applications are open for the OUCH-International and LCRF Research Grant Program on the Effects of Air Pollution and Climate Change on Carcinogenesis and #LungCancer Prevalence. This collaboration seeks to fund projects studying the effect of climate on lung cancer. Read more: LCRF.org/rfp-OUCHI

LCRF is now accepting research program applications, advancing its mission to address critical challenges in #LungCancer by improving early detection, deepening understanding of lung cancer biology, overcoming drug resistance, and developing innovative treatment approaches. LCRF.org/RFPannouncement

Applications are now open for the OUCH-International and LCRF Research Grant Program on the Effects of Air Pollution and Climate Change on Carcinogenesis and #LungCancer Prevalence. View RFP and apply at LCRF.org/funding#OUCH.

#LungCancer research RFPs open: LCRF is accepting Letters of Intent for its 2026 grant program, which includes tracks on overcoming resistance, early detection, and leading edge research. View RFPs and apply: LCRF.org/funding

LCRF's Sr. Dir. Research & Administration, Dr. Dhru Deb, explains how early funding for NTRK gene fusion research led to the first targeted therapy for this driver. Our commitment to #LungCancer research continues to make an impact. Read more: LCRF.org/connecting3

New Year. New Goals. Go the Distance for Lung Cancer Research. Team LCRF is looking for runners and cyclists to go the distance for lung cancer research in the United Airlines NYC Half on March 15 and the TD Five Boro Bike tour on May 3! TeamLCRF.org 🏅

LCRF is pleased to announce five additional award recipients for its 2025 #LungCancer research grant program. Read more: LCRF.org/gr16a

Advice to the newly diagnosed. www.tiktok.com/t/ZP8yG66dB/ #cancer #lungcancer #lcsm

“Lung cancer tried to take my life three times. Research saved me—three times.” Judith’s story isn’t just powerful—it’s possible because of donors like you. Right now, someone else is waiting for their breakthrough. Give before midnight to DOUBLE your impact! LCRF.org/thirdchance

Today’s the last day to make a tax-deductible gift in 2025—and the last chance to have your donation DOUBLED. Judith survived #LungCancer three times, thanks to research made possible by donors like you. Give now and make 2x the impact: LCRF.org/thirdchance

#LungCancer is still surrounded by silence and stigma—but Judith, a 3x survivor, fights to make lung cancer impossible to ignore. Your support funds the research that saves lives. Donate by Dec 31 to DOUBLE your gift. End the stigma. End lung cancer. LCRF.org/thirdchance

“None of us are alone in this.” When Shane’s mom was diagnosed with #LungCancer, he found hope through community—and through research that gave her more time. Your support fuels that same hope. Donate by Dec 31 to double your gift and help fund the next breakthrough. LCRF.org/thirdchance

Yesterday, the FDA approved subcutaneous amivantamab for adult patients with EGFR-mutated non-small cell lung cancer (NSCLC.) This approval means shorter treatment times and fewer side effects. #lungcancer #QOL #lcsm www.fda.gov/drugs/resour...

“What gave me more time? Research.” Judith survived 3 #LungCancer diagnoses over two decades. Stories like hers used to be rare—but thanks to research funded by donors like you, patients have more treatment options than ever. Give by Dec 31 – your donation will be DOUBLED. LCRF.org/thirdchance

UT Health San Antonio and Mays Cancer Center are hosting the Advancing Cancer Research for Latinos and All Populations conference, Feb 18-20, 2026. Gain perspective on cancer health issues. Early bird registration through 12/18! #CancerResearchForAll #ACRLP LatinoCancer.org

THREE #LungCancer diagnoses—and Judith is still here. “Chemo, surgery, radiation, clinical trials… and hope. I’m alive today because of life-saving research—and people like YOU who make it possible.” Give by Dec 31 and your donation will be matched! LCRF.org/thirdchance

This is the perfect time of year to set a goal to participate in some of New York's iconic endurance events! Team LCRF is looking for runners and cyclists to go the distance for lung cancer research in the United Airlines NYC Half on March 15 and the TD Five Boro Bike tour on May 3! TeamLCRF.org 🏅

This morning, Will Reeve shared the stories and statistics behind the increase in lung cancer among women and non-smokers, and how new treatments are helping people live longer, with research bringing new hope. #AnyoneWithLungs #LungCancer #ResearchIsHope LCRF.org/gmc129

Announcing the 2025 LCRF | Boehringer Ingelheim Early Career Investigator Awards: three awardees each received a $250k grant for projects focused on HER2-driven lung cancer. Read more about these scientists and the focus of their studies. LCRF.org/251209bi

You did something incredible yesterday. Thanks to your generosity this #GivingTuesday, we’re one step closer to breakthroughs in #LungCancer detection, treatment, and prevention. Your gift is already at work, fueling research & giving hope to thousands of families. From all of us at LCRF: thank you.

Today is #GivingTuesday — and your gift has never mattered more. This year, we received a record number of proposals — actionable, innovative research that could transform the future of #LungCancer. Until midnight tonight – your gift is doubled, thanks to a generous donor! LCRF.org/givingtuesday

Tomorrow, Dec. 3 @ 4pm ET — Together Separately livestream on #LungCancer breakthroughs of 2025. @balazshalmos.bsky.social & Dr. Lyudmila Bazhenova will join Dr. Isabel Preeshagul to look back upon all of the exciting research in 2025 and discuss what's to come: LCRF.org/together

#ScienceMadeSimple: FDA has granted accelerated approval to sevabertinib for treating HER2+ (ERBB2) #LungCancer. LCRF's Chief Scientific Officer, Dr. Toni Wozniak, explains what this means for patients. LCRF.org/sms25121

LCRF is pleased to announce this year's 2025 Scientific Grant Program awards. Eleven awardees received a total $1.65 million in funding for new #LungCancer research. Read more about these scientists and the focus of their studies. LCRF.org/2025awards

Today is #GivingTuesday, and your donation to fund critical #LungCancer research will be DOUBLED thanks to a generous donor! Please give and fuel more breakthroughs that give hope to patients and families. LCRF.org/givingtuesday

We’ve never seen this much promise in #LungCancer research — but we can’t fund it all without you. LCRF.org/givingtuesday "LCRF funding was instrumental in allowing me to complete and publish my project… now it’s the foundation of a clinical trial.” — Dr. Victoria Wang, Two-time LCRF Grantee

Lung Cancer Awareness Month is coming to a close, but the reality is that #LungCancer deserves attention every day of the year. Keep the momentum going, and let's head into the coming year full of hope and determined to make a difference for everyone affected by this disease. #LCAM LCRF.org/LCAM

#FridayFacts: #LungCancer survivorship rates are increasing faster than ever, thanks to early detection and advances in research. Spread the word! Find graphics and information you can share at LCRF.org/LCAM. #LCAM

On #Thanksgiving day, "family" is a word with great meaning. And when you care about people with #LungCancer, you become part of our second family. We hope that you are enjoying time with people you love. We are grateful for you and all you do! #HappyThanksgiving

More women are lost to #LungCancer than to breast, cervical, and ovarian cancer combined. If you have lungs, you can get lung cancer. Learn more about how this disease affects women: LCRF.org/women #LCAM #WomenLC

Proud to represent LCRF at US Rep. Josh Gottheimer's event announcing several bills to benefit the #LungCancer community, with Dusty Donaldson, Valerie Brown, Dr. Upal Basu Roy, and LCRF board member Benay Taub, for whom the Benay Taub Lung Cancer Research Act is named. LCRF.org/taubact

More researchers than ever have submitted bold, promising projects to LCRF — ideas that could change everything. Now more than ever, your support can help turn powerful ideas into real-life impact. #GivingTuesday is almost here. Will you help us fund the future? LCRF.org/givingtuesday

It's a fact: #LungCancer screening saves lives! LCRF is partnering with the American Lung Cancer Screening Initiative on the #PlusOne campaign, which asks: “Do you have a friend or loved one who is eligible for lung cancer screening?” Learn more at LCRF.org/PlusOne. #LCAM

We're grateful for the scientific discoveries and continued progress made possible by funding #LungCancerResearch. Learn about recent approvals for treatment: LCRF.org/FDA. Fund more research this Lung Cancer Awareness Month! LCRF.org/LCAMyourWay #LCAM

#FridayFacts: #LungCancerResearch saves lives! More treatments were developed in the past decade than in the 7 decades before. Let's keep that trend going! Find out how you can help: LCRF.org/LCAM. #LCAM2025

#anyonewithlungs can get lung cancer. Period.

While every diagnosis is one too many, the #LungCancer diagnosis rate is declining. Find out what you can do to keep that trend going: LCRF.org/LCAM #LCAM